C4 Therapeutics Inc CCCC Valuation Ratios and Share Stats

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
C4 Therapeutics Inc (CCCC)
C4 Therapeutics Inc (CCCC) Financials

C4 Therapeutics Inc (CCCC)

6.80

0.35

(5.43%)

Closed May 09 4:00PM

Delayed by 15 minutes

6.91

0.11

(1.62%)

After Hours: 7:39PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-32.913	-32.156	-25.592	-18.501	-27.341	-32.824
Return on Equity (%)	60.456	44.407	-78.583	-25.028	-37.763	-49.498
Return on Invested Capital (%)	-114.337	-288.628	-42.059	-30.273	-62.142	-74.932
Operating Margin (%)	-81.135	-155.722	-198.018	-178.545	-405.065	-625.554
Net Profit Margin (%)	-124.494	-199.088	-199.834	-183.23	-412.191	-638.336
Book Value Per Share	23.335	-0.678	6.512	8.002	5.907	4.994
Earnings Per Share	-18.004	-29.83	-1.538	-1.723	-2.618	-2.689
Cash Per Share	27.118	63.454	4.215	1.563	0.608	2.569
Working Capital Per Share	74.37	44.237	7.819	5.637	4.963	4.635
Operating Profit Per Share	14.462	14.983	0.77	0.94	0.635	0.421
EBIT Per Share	-11.733	-23.332	-1.553	-1.723	-2.618	-2.663
EBITDA Per Share	-11.733	-23.332	-1.553	-1.723	-2.618	-2.663
Free Cash Flow Per Share	-16.946	-30.002	-1.561	-1.727	-2.54	-2.692

Liquidity Ratios

Year End December 30 2023	2018	2019	2020	2021	2022	2023
Current Ratio	5.158	2.876	8.689	6.355	6.455	6.341
Quick Ratio	5.125	2.829	8.578	6.147	6.232	6.208
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	1.34M	1.43M	43.12M	48.69M	48.97M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	48.59M	48.69M	48.75M	N/A	48.95M	48.97M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-406.232	N/A	N/A	N/A	-909.125	N/A
Net Profit Margin (%)	N/A	N/A	-413.117	N/A	N/A	N/A	-925.246	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	6.447	N/A	N/A	N/A	7.071	N/A
Quick Ratio	N/A	N/A	6.235	N/A	N/A	N/A	6.878	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	467.86M
Price to Earnings Ratio	-3.53
Price to Sales Ratio	22.54
Price to Cash Ratio	3.7
Price to Book Ratio	1.9
Dividend Yield	-

Share Statistics

Shares Outstanding	68.6M
Average Volume (1 week)	1.28M
Average Volume (1 Month)	1.27M
52 Week Change	117.30%
52 Week High	11.88
52 Week Low	1.06

More Ratios Coming Soon!

C4 Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions